Effect of Plyometric Exercise on Stability in Professional Indoor Soccer Players: A Pilot Study (PESF)

March 29, 2023 updated by: Inmaculada Ruiz Lopez, Universidad Católica San Antonio de Murcia
A program is proposed for two groups of professional indoor soccer players where the effect of plyometric exercises on body stability will be evaluated on a stabilometric platform.

Study Overview

Status

Active, not recruiting

Detailed Description

A program is proposed for two groups of professional indoor soccer players where the effect of plyometric exercises on body stability will be evaluated on a stabilometric platform.

Four evaluations will be carried out. An initial measurement before the beginning of the first intervention phase (Visit 1), after the intervention (Visit 2; day 30), after a 15-day washout period (Visit 3; day 45) and after the second intervention phase (Visit 4; day 75).

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Murcia, Spain, 30107
        • Universidad Católica San Antonio de Murcia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Professional soccer player in the first division of the National Soccer League (LNFS).
  • Age between 18 and 35 years old.
  • BMI between 18 and 32 Kg/m2.

Exclusion Criteria:

  • Serious or terminal illness.
  • Participants with pain associated with chronic conditions.
  • Participants with body mass index above 32 kg/m2.
  • Inability to understand the informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Plyometric exercise
The group of athletes will perform plyometric stability exercises and their usual exercise for 30 days.
The group of athletes will perform plyometric stability exercises and their usual exercise for 30 days.
Other: Regular exercise
The group of athletes will their usual exercise for 30 days.
The group of athletes will perform their usual exercise for 30 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance Phase 1
Time Frame: Baseline and end of each intervention [Day 0 and day 30].
Measurement of the balance measured as a percentage by pressure platform of professional indoor soccer players.
Baseline and end of each intervention [Day 0 and day 30].
Balance Phase 2
Time Frame: Baseline and end of each intervention [Day 45 and day 75].
Measurement of the balance measured as a percentage by pressure platform of professional indoor soccer players.
Baseline and end of each intervention [Day 45 and day 75].

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flexibility
Time Frame: Baseline and end of each intervention [Day 0 and day 30].
Flexibility will be measured with goniometer.
Baseline and end of each intervention [Day 0 and day 30].
Flexibility
Time Frame: Baseline and end of each intervention [Day 45 and day 75].
Flexibility will be measured with goniometer.
Baseline and end of each intervention [Day 45 and day 75].
Flexibility
Time Frame: Baseline and end of each intervention [Day 0 and day 30].
Flexibility will be measured with Lunge test.
Baseline and end of each intervention [Day 0 and day 30].
Flexibility
Time Frame: Baseline and end of each intervention [Day 45 and day 75].
Flexibility will be measured with Lunge test.
Baseline and end of each intervention [Day 45 and day 75].
Number of injuries
Time Frame: Baseline and end of each intervention [Day 0 and day 30].
The number of lesions will be collected during the course of the study.
Baseline and end of each intervention [Day 0 and day 30].
Number of injuries
Time Frame: Baseline and end of each intervention [Day 45 and day 75].
The number of lesions will be collected during the course of the study.
Baseline and end of each intervention [Day 45 and day 75].
Lower limb pain
Time Frame: Baseline and end of each intervention [Day 0 and day 30].
Pain intensity will be measured with a Visual Analog Score (minimum value 0 - Maximum value 10). Higher values indicate a greater degree of pain
Baseline and end of each intervention [Day 0 and day 30].
Lower limb pain
Time Frame: Baseline and end of each intervention [Day 45 and day 75].
Pain intensity will be measured with a Visual Analog Score (minimum value 0 - Maximum value 10). Higher values indicate a greater degree of pain
Baseline and end of each intervention [Day 45 and day 75].
Anthropometric measurements
Time Frame: Baseline and end of each intervention [Day 0 and day 30].
Anthropometric variables measured with a TANITA equipment.
Baseline and end of each intervention [Day 0 and day 30].
Anthropometric measurements
Time Frame: Baseline and end of each intervention [Day 45 and day 75].
Anthropometric variables measured with a TANITA equipment.
Baseline and end of each intervention [Day 45 and day 75].

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Universidad Católica San Antonio de Murcia Universidad Católica San Antonio de Murcia, Universidad Católica San Antonio de Murcia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2023

Primary Completion (Anticipated)

April 1, 2023

Study Completion (Anticipated)

July 1, 2023

Study Registration Dates

First Submitted

February 2, 2023

First Submitted That Met QC Criteria

March 7, 2023

First Posted (Actual)

March 8, 2023

Study Record Updates

Last Update Posted (Actual)

March 30, 2023

Last Update Submitted That Met QC Criteria

March 29, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • UCAM CE012305

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plyometric Exercises

Clinical Trials on Plyometric exercise

Subscribe